Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 163   

Articles published

NVS 78.96 -0.29 (-0.37%)
price chart
Novartis AG (ADR) (NVS) Multiple Sclerosis Molecule: Ray of Hope
Novartis AG (ADR) (NYSE:NVS) investigational molecule for the treatment and management of multiple sclerosis has shown remarkable reduction in the disease progression up to 21%.
Here's What's Important With The Novartis AG (ADR) (NVS) MS Data
Novartis AG (ADR) (NYSE:NVS) just put out data from its multiple sclerosis (MS) trial, and it looks as if the company is winning the race to bring a drug to market that offers a solution for patients with secondary progressive MS (SPMS), a severe form ...
Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words  Market Exclusive
Novartis AG (NYSE:NVS) Fights for Survival after Patent Expiration  TCC
Activity Reported By SEC: Ls Investment Advisors LLC Lowered Its Novartis Ag ...
Ls Investment Advisors Llc decreased its stake in Novartis Ag Spon Adr (NVS) by 97.91% based on its latest 2016Q2 regulatory filing with the SEC.
Will Novartis AG (ADR) (NVS) Clinch Biosimilar Market by 2020?
Novartis AG's (ADR)(NYSE:NVS) biosimilar and generic division, Sandoz is working for the development of novel biosimilars versions of the blockbuster drugs to patch up the revenue loss of its blockbuster drugs' patents.
Novartis AG (ADR) (NYSE:NVS) Heffx Trading Outlook
During the past 10 bars, there have been 7 white candles and 3 black candles for a net of 4 white candles. During the past 50 bars, there have been 29 white candles and 21 black candles for a net of 8 white candles.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis AG (ADR) (NYSE:NVS): Reviewing Earnings Estimates
Novartis AG (ADR) (NYSE:NVS) soared 0.51% or +0.42 points during previous trade after opening at the price of $81.92, a total of 1.58M shares exchanged hands compared with its average trading volume of 1.71M shares.
Novartis AG (ADR) 2Q Earnings: Here's What To Expect?  Bidness ETC
Will Novartis AG (ADR) (NVS) be Forbidden in Korea after Bribe Charges?
Novartis AG (ADR) (NYSE:NVS) is hit by bad news of involvement of its six senior officials under the charges of corruption.
Novartis AG (NYSE:NVS) To Spend $100 Million On Expansion Of French mAb Plant  Market Exclusive
Amgen, Inc. (AMGN) and Novartis AG (ADR) (NVS) Erenumab: New Hope for Migraine ...
Amgen, Inc. (NASDAQ:AMGN) has announced that erenumab clinical results for the management and treatment of chronic migraine headaches have met the primary endpoints.
Novartis AG (ADR) 17% Potential Upside Now Implied by Chardan Capital Markets
Novartis AG (ADR) with TICKER NYSE:NVS has had its stock rating noted as 'Initiated' with the recommendation being set at 'BUY' yesterday by analysts at Chardan Capital Markets.